Patel Engineering Q2 Profit Jumps 63% to Rs 32 cr - PTI
By Rediff Money Desk, NEWDELHI Nov 03, 2023 14:06
Patel Engineering reports a 63% surge in Q2 profit to Rs 32.1 crore, driven by increased revenue. The company's revenue also rose significantly during the quarter.
New Delhi, Nov 3 (PTI) Integrated infrastructure and construction services firm Patel Engineering on Friday reported 63 per cent rise in consolidated net profit at Rs 32.1 crore for the quarter ended September 30, 2023.
The company had posted a profit of Rs 19.7 crore for the year-ago period, Patel Engineering said in a statement.
Revenue from operations increased to Rs 1,021.3 crore from Rs 830.3 crore in the year-ago period.
"With a surge in revenue and profitability, we've showcased our adaptability and resilience in the face of economic challenges," company's Chairman & Managing Director Rupen Patel said.
The company had posted a profit of Rs 19.7 crore for the year-ago period, Patel Engineering said in a statement.
Revenue from operations increased to Rs 1,021.3 crore from Rs 830.3 crore in the year-ago period.
"With a surge in revenue and profitability, we've showcased our adaptability and resilience in the face of economic challenges," company's Chairman & Managing Director Rupen Patel said.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.08 ( -3.92)
- 65128261
- Thinkink Picturez
- 1.77 ( -0.56)
- 47207415
- Sunshine Capital
- 2.32 (+ 4.98)
- 18775443
- Evexia Lifecare
- 4.07 (+ 3.30)
- 16083406
- Cressanda Railway
- 11.19 (+ 4.97)
- 15151945
MORE NEWS
India Pushes for Fast-Track WTO Talks on...
India has called for expedited negotiations in the WTO on the Special Safeguard...
Sensex Surges 809 Points Ahead of RBI Policy
The BSE Sensex rallied 809 points on Thursday, led by IT stocks, ahead of the RBI's...
Aurobindo Pharma Gets USFDA Approval for...
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities, has received USFDA approval...